Purpose: To provide a fast computational method, based on the proximal graph solver (POGS) -A convex optimization solver using the alternating direction method of multipliers (ADMM), for calculating an optimal treatment plan in rotating shield brachytherapy (RSBT). RSBT treatment planning has more degrees of freedom than conventional high-dose-rate brachytherapy due to the addition of emission direction, and this necessitates a fast optimization technique to enable clinical usage. Methods: The multi-helix RSBT (H-RSBT) delivery technique was investigated for five representative cervical cancer patients. Treatment plans were generated for all patients using the POGS method and the commercially available solver IBM ILOG CPLEX. The rectum, bladder, sigmoid colon, high-risk clinical target volume (HR-CTV), and HR-CTV boundary were the structures included in our optimization, which applied an asymmetric dose-volume optimization with smoothness control. Dose calculation resolution was 1 9 1 9 3 mm 3 for all cases. The H-RSBT applicator had 6 helices, with 33.3 mm of translation along the applicator per helical rotation and 1.7 mm spacing between dwell positions, yielding 17.5°emission angle spacing per 5 mm along the applicator. Results: For each patient, HR-CTV D 90 , HR-CTV D 100 , rectum D 2cc , sigmoid D 2cc , and bladder D 2cc matched within 1% for CPLEX and POGS methods. Also, similar EQD2 values between CPLEX and POGS methods were obtained. POGS was around 18 times faster than CPLEX. For all patients, total optimization times were 32.1-65.4 s for CPLEX and 2.1-3.9 s for POGS. Conclusions: POGS reduced treatment plan optimization time approximately 18 times for RSBT with similar HR-CTV D 90 , organ at risk (OAR) D 2cc values, and EQD2 values compared to CPLEX, which is significant progress toward clinical translation of RSBT.
INTRODUCTION
High-dose-rate brachytherapy (HDR-BT) involves placing a radiation source inside of or adjacent to a target organ, that is, tumor. Conventional HDR-BT uses an unshielded brachytherapy source with a radially symmetric dose distribution, 1, 2 which limits the intensity modulation capacity of the approach. Rotating-shield brachytherapy (RSBT) has a rotating radiation-attenuating shield around a brachytherapy source. The RSBT concepts for single-catheter treatment 3 and multicatheter treatment 4 were introduced by Ebert. In the multihelix RSBT (H-RSBT) treatment 5 (Fig. 1) , a radiation source travels inside a tandem of Henschke Applicator having helical keyways. A keyway is a helical slot wound inside of the applicator, which provides a pathway for the shield to move along, when the coupled source is translated, to ensure its correct orientation. While moving along the applicator for a given keyway, the partial shield rotates around the radiation source simultaneously. Due to the design of the applicator, the position of the source in the applicator dictates the direction of the open part of the shield. In traveling along each keyway, the radiation source stops at designated dwell positions. Intensity-modulated dose distributions can be delivered to the target with reduced dose exposure to nontarget organs by controlling the treatment time in an optimal manner for each dwell position. Hence, a radiation source with rotating shields can deliver more conformal dose distributions than an unshielded radiation source. 5 Unlike the conventional HDR-BT optimization using inverse planning based on given clinical prescription, [6] [7] [8] [9] [10] [11] [12] the RSBT optimization problem has the additional optimization variables of radiation exposure time at each angle of the shield. Due to the increased degrees of freedom in RSBT, RSBT optimization is more difficult than that for the conventional HDR-BT. In addition, it is desirable to quickly obtain optimal treatment plans in RSBT to enable clinical usage. To achieve this, researchers have used the dose-surface optimization (DSO) method, 13, 14 which minimizes the total dose errors over only voxels on the HR-CTV surface. Instead of dealing with only voxels on the HR-CTV surface, Liu et al. 15 included voxels on the surface of HR-CTV as well as voxels inside of tumor in certain distance range from the applicator in their optimization problem. Additionally, the authors used the total variation (TV) norm penalty in the optimization problem to make smooth changes in the emission times of adjacent beams in the treatment process to facilitate the efficient delivery of an RSBT plan. This optimization approach for RSBT is called asymmetric dose-volume optimization with smoothness control (ADOS).
In this paper, the ADOS optimization problem, which is a large-scale RSBT optimization problem, is investigated. A fast computational method is proposed to solve the ADOS optimization problem for the optimal cancer treatment planning for RSBT. Liu et al. used a commercial optimization solver called CPLEX. 15, 16 In order to efficiently solve the ADOS optimization problem, an optimization method based on the proximal graph solver (POGS), 17 which is a solver using the alternating direction method of multipliers (ADMM), was designed. For this purpose, the closed-form formulas for the proximal operators used in POGS were derived. Furthermore, the proposed method was applied to H-RSBT, which is a mechanically feasible delivery technique for RSBT proposed by Dadkhah et al. 5 In this paper, the proposed methodology was applied to the treatment of cervical cancer, even though the method is also applicable to other types of cancer such as breast cancer and prostate cancer.
MATERIALS AND METHODS

2.A. Delivery method
In order to deliver the radiation dose to a target organ, a mechanically feasible delivery technique for RSBT, called H-RSBT, 5 is considered. Figure 1 shows the illustration of the H-RSBT method. The shield opening is represented by the azimuthal and zenith emission angles, denoted by Dφ and Dh, respectively.
In H-RSBT, an Xoft Axxent radiation source, inside its cooling catheter, with a freely rotating partial radiation shield is translated inside an applicator with six helical keyways carved out of the inner wall. The six keyways are evenly spaced by 60°on the applicator cross section, and each keyway has a helical pitch of one rotation per 33.3 mm of translation. The partial shield has a protruding key that travels down a given keyway, and, due to the helical design of the keyways, the shield rotates about the radiation source as the source catheter is translated, and the emission angle of the shield is fixed for a given keyway and translational dwell position. As the H-RSBT applicator has six helices, with 33.3 mm of translation along the applicator per helical rotation and 1.7 mm spacing between dwell positions, it yields 17.5°of rotation for the shield per 5 mm (standard dwell position spacing) of its translation along the applicator. The dose calculation resolution was 1 9 1 9 3 mm 3 for all cases. The transmission through the shield was 0.1% and approximated to be 0% for the dose calculation. For all treatment plans, an azimuthal emission angle of 45°was used. The zenith emission angle of the modeled shields was an asymmetric 116°, which is consistent with previous work. 5 
2.B. Radiation source model and dose calculation
For H-RSBT, the delivery is parameterized by keyway number and dwell position number along the keyway. To quantitatively describe the structure of high-dose regions formed by a partially shielded source, the notation of beamlet is introduced. A beamlet, denoted by D i (j,b), is defined as the dose rate at point r i with the shielded source positioned at the j-th dwell position while the shield is aligned with the b-th keyway. To calculate the beamlet, the TG-43 dose calculation model of Rivard et al. 18 is used. The radiation source is assumed to be partially shielded 50 kVp Xoft Axxent TM (Sunnyvale, CA, USA). To be consistent with previous work, 13, 14, 19 it is assumed that the dose to the points blocked by the shield is 0, since the transmission rate from 50 kVp Xoft Axxent TM can be controlled to be less than 0.1% when using a 0.5 mm tungsten shield. 13, 14 Then, the radiation dose amount at the point r i , denoted by d i , can be quantified as a time-weighted sum of all beamlets as follows:
where t j,b is the dwell time of beamlet D i (j,b). The next subsection describes the RSBT optimization problem having asymmetric penalty parameters for HR-CTV and organs at risk (OARs), with TV regulation term for smoothness in the beamlet emission times.
2.C. Optimization problem for cancer treatment planning in RSBT
2.C.1. Problem formulation
Let t 2 R mn Â 1 be the beamlet emission time vector for all keyways and all dwell positions, where m and n are the number of keyways, that is, m = 6, and the number of dwell positions along a keyway, respectively. t can be obtained by vectorizing t j,b in Eq. (1); namely, the vector t 2 R mnÂ1 is a concatenated vector, which is expressed as t
where t½j 2 R n Â 1 is the dwell time vector for all the beamlets along a keyway, and the super-script T represents the transpose. Let us define a concatenated dose rate matrix D ¼ ½D½1; D½2; . . .; D½m 2 R l Â mn , where D½j 2 R l Â n , j = 1,. . .,m, is the dose rate matrix for the j-th selected keyway, and l is the number of voxels of interest (VOIs). The whole index set for voxels of interest is denoted as I VOIs and the index set for HR-CTV, bladder, rectum, sigmoid, and normal tissue around the HR-CTV as I tumor , I bladder , I rectum , I sigmoid , and I normal respectively. The dose rate matrix D has information about dose rate delivered to each tissue point in I VOIs from each beamlet.
The following RSBT optimization problem is considered, where the objective function includes a term representing the quadratic dosimetric objective function, and a term that regulates the total variation for smooth beamlet emission times. Equation (2) represents an optimization problem that can be solved using graph projection splitting method 17,20 as described below.
where D 2 R lÂmn is a dose rate matrix, t ≥ 0 is the elementwise non-negative emission time, d i is the dose amount at the i-th voxel as introduced in Eq. (1). In Eq. (2),
is the unit step function with H(a) = 1 if a > 0, and H(a) = 0 if a ≤ 0, and k þ i and k À i represent overdose and underdose penalty parameters for the i-th voxel, respectively.d i represents the prescribed dose amount for the i-th voxel.d i can have a different value for each VOI. For example,d i ¼d tumor if i 2 I tumor , andd i ¼d bladder if i 2 I bladder . The prescribed dose amount for HR-CTV, bladder, rectum, sigmoid, and normal tissue around the HR-CTV are denoted asd tumor ,d bladder ,d rectum , d sigmoid , andd normal , respectively. For k þ i and k À i , different nonnegative overdose and underdose parameter values including 0 are used. For a vector x 2 R n , ‖x‖ 1 is defined as the sum of the absolute value of each element of x, that is, kxk 1 , P n i¼1 jx i j. The matrix L 2 R nÂn is introduced to calculate TV norm of a vector; namely, L is defined as follows: :
The TV norm alleviates the positioning uncertainty in the treatment process. If two noticeably different emission times t j,b and t j+1,b between two adjacent beamlets along the same keyway are obtained, a small error in the dwell positions may cause an unacceptable treatment result. By applying the smoothness term between two adjacent beamlets along the same keyway in H-RSBT, the treatment error caused by the positioning uncertainty in the treatment process can be reduced.
Since different penalty parameter values for the overdose and underdose of a voxel are used, Eq. (2) is denoted as RSBT optimization problem having asymmetric penalty parameters or simply ADOS.
2.C.2. POGS implementation
In order to simplify the sum of the TV norms in Eq. (2), let us introduce a matrix L , I mÂm L, where ⊗ is the Kronecker product, and I m9m is an m9m identity matrix. By assigning
Lt ¼ y and introducing the indicator function I(Á), Eq. (2) is restated as follows:
where D 2 R lÂmn , L 2 R mnÂmn , and I(t ≥ 0) is the elementwise indicator function; namely, I(t i ≥ 0) = 0 if t i ≥ 0, and
By letting
Eq. (3) can be further simplified into minimize t2R mn ;z2R lþmn
where z [a:b] is the partial vector of z by taking vector z from the a-th element to the b-th element. The following functions are defined as
Then Eq. (4) is converted into a graph-form convex optimization problem, 17 where the constraint is z = At, and A ¼ ½D T L T T 2 R ðlþmnÞÂmn . The detailed updating rules for each optimization variable in the POGS solver for Eq. (4) are described below. The derived results in detail for the proximal operators used in the POGS solver, updating steps, and stopping criteria are introduced as follows.
The POGS updates primal variables, conducts the projection onto the space z = At, and then, updates dual variables iteratively until the stopping criteria are satisfied or the maximum number of iterations, denoted by MaxItr, is reached. The primal variable and dual variable are updating variables to be used for optimality condition in the algorithm. For the primal variable, dual variable, and projection result, ðt;ẑÞ, (t,z), and ðt;zÞ are used, respectively. Each updating step is introduced in detail for the optimization problem in Eq. (4). The super-script k is used to represent the k-th iteration.
Updating primal variablest kþ1 andẑ kþ1 : In updating the primal variables, the following proximal operators with a penalty parameter q are used:
The proximal operator is used to make a compromise between the solution at the k-th iteration and the function value with the solution at the k+1 iteration. Closed-form formulas for the proximal operators can be explicitly derived. t kþ1 2 R mn is stated as follows:
where max(a,b) provides the maximum value between a and b element-wise.ẑ kþ1 i , 1≤i≤l is derived as follows:ẑ
Forẑ kþ1 i , l+1 ≤ i ≤ l+mn, the following derivation is obtained:
POGS uses the adaptive value for q as default to further increase the convergence speed. Projection onto z = At from ðt kþ1 þt k ;ẑ kþ1 þz k Þ: The projection operation is mapping the primal variables to the closest feasible solution. The projected variables onto z = At from ðt kþ1 þt k ;ẑ kþ1 þz k Þ, denoted as t k+1 and z k+1 , are obtained by solving the following optimization:
By solving this optimization and using Lagrange conditions, 21 the following formulation is obtained:
Updating dual variablest kþ1 andz kþ1 : The dual variable at iteration (k+1) is obtained by updating the dual variable at the k-th iteration as follows:
t kþ1 ¼t k þt kþ1 À t kþ1 ;
z kþ1 ¼z k þẑ kþ1 À z kþ1 :
Algorithm 1 summarises the updating steps.
Stopping criteria: For the stopping criteria, the primal and dual residuals are defined as follows:
Here, pri and dual are positive tolerances for primal and dual residuals, respectively:
where ( abs , abs )=(10 À4 ,10 À2 ) were used in the numerical experiments.
Algorithm 1: Fast treatment planning for RSBT in POGS implementation
Input:
Output: t Initialize: k 0, t k 0, z k 0,t 0,z 0 for k = 1 to MaxItr do Updating primal variablest kþ1 ,ẑ kþ1 :
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Algorithm 1: Fast treatment planning for RSBT in POGS implementation t kþ1
Prox g ðt k Àt k Þ . See (7) z kþ1 Prox f ðz k Àz k Þ . See (8) and (9) Projection onto z = At:
Updating dual variablest kþ1 ,z kþ1 :
if Stopping criteria are met then break end end
2.D. Treatment planning
This study used the same dataset as the previous studies by Liu et al. 15 and Dadkhah et al., 5 which included five patients treated for cervical cancer with HR-CTV volumes ranging from 42.2 to 98.8 cm 3 . Table I shows the volume and maximum dimension of HR-CTV for five patients. All the HR-CTVs and OARs were manually contoured by physicians on T2 weighted 1 9 1 9 3 mm 3 resolution MR images taken with a Siemens MAGNETOM 3T scanner (Siemens, Germany) at the beginning of the first fraction of brachytherapy. A titanium Fletcher-Suit-Delclos style tandem and ovoids (Varian Medical Systems, Palo Alto, CA, USA) were used as the brachytherapy applicator.
All the patients had external beam radiation treatment in 25 fractions at 1.8 Gy/fraction. It was assumed that the external beam radiotherapy dose was delivered equally to all of the voxels in HR-CTV for all the patient cases. The dose in each voxel was converted to equivalent dose in 2 Gy per fraction of external radiation therapy (EQD2) using the linear quadratic model, 22 where the linear-quadratic parameter, a/b, is set to 3 Gy for OARs and 10 Gy for HR-CTV.
For VOIs, the voxels located at a distance between 3 mm and 20 mm to the radiation source path or those within 10 mm inside and outside of the HR-CTV boundary surface were included. 15 The HR-CTV, HR-CTV boundary, bladder, sigmoid, and rectum inside of VOIs in the optimization problem were considered. The optimization parameter settings are shown in Table II . Table III shows the dimension of the dose matrix D in Eqn. (2) .
For all the brachytherapy treatment plans, the EQD2 of the HR-CTV was escalated without exceeding the D 2cc tolerance of the bladder, rectum, and sigmoid colon. 90 Gy for bladder tolerance, and 75 Gy for rectum and sigmoid colon tolerances were used according to Groupe Europ een de Curieth erapie, European Society for Therapeutic Radiology and Oncology (GEC ESTRO). 23, 24 Since the goal of this research is to achieve a fast solution to the RSBT dose optimization problem without compromising the plan quality, the execution times to solve Eq. (2) were compared for all five patient cases. The numerical experiments were conducted on HP Z220 CMT with an Intel Core i7-3770 dual core CPU @3.4 GHz clock speed and 16 GB DDR3 RAM, using Matlab (R2013b) on the Windows 7 operating system.
2.E. Treatment plan evaluation
Optimized treatment plans were generated for all patients using the POGS method and the previously investigated CPLEX method. 15 The same objective function, with the same input parameters and beamlets, was minimized for each patient with both methods. A total variation term was included in the objective function as a regularization term, resulting in smoothly varying emission times along each keyway. The regularization promotes robustness of the resulting overall dose distribution with respect to small errors (expected ≤ 1 mm) in source positioning. The rectum, bladder, sigmoid colon, HR-CTV, and HR-CTV boundary were the structures considered.
POGS method was compared with the previous research conducted by Liu et al. 15 using CPLEX 16 for H-RSBT. It was evaluated that the quality of the delivery plans as well as the execution time to solve Eq. (2) with POGS. 17 The comparison metrics for the quality of the delivery plans are the HR-CTV D 90 , HR-CTV D 100 , D 2cc of all OARs, DVH, and dose distributions considered.
RESULTS
Results for five cervical cancer patient cases are shown in Table IV . Figure 2 shows the corresponding DVH in H-RSBT. With the same parameter settings as in Table II , POGS can achieve an RSBT plan with almost the same D 90 value (less than 1% difference) as that achieved by CPLEX in each of the five patient cases. D 2cc values for OARs obtained by POGS are within 1% of the values obtained using CPLEX. For the execution time, approximately 18 times faster speed to solve the ADOS problem for H-RSBT was achieved than the CPLEX-based method on average. For all patients, total optimization times were 32.1-65.4 s for CPLEX and 2.1-3.9 s for POGS. Figure 3 shows that the EQD2 dose distributions were nearly identical for both methods.
DISCUSSION
Studying optimization algorithms in radiotherapy aims to reduce the treatment planning time as well as to improve the quality of the treatment. Especially, the inverse planning by simulated annealing (IPSA) technique optimizes the DVH directly with given constraints in heuristic way 6 and is used in clinical treatment planning system of Oncentura (Elekta Inc., Atlanta, GA, USA). 11 The IPSA has been reported as favorable dosimetric plans. 25 However, due to its heuristic nature, resulting increased degree of freedom, and its nonconvex optimization problem, the IPSA suffers from its computational time 26 and a global solution is not guaranteed. Thus, its solution may not be clinically robust enough. Instead of directly optimizing DVH, the ADOS optimization problem is expressed as a convex optimization problem. Both CPLEX and POGS provide the same globally optimal solutions, but POGS presented 18 times fast computational efficacy.
The proposed POGS method is not limited to RSBT. In general it is applicable to all intensity-modulated brachytherapy (IMBT) approaches including dynamic-modulated brachytherapy (DMBT), [27] [28] [29] [30] [31] conventional HDR-BT, and pulse-dose-rate (PDR) brachytherapy for which the previously tested optimization techniques such as dose-surface optimization (DSO) and IPSA are implemented. In this study, the proposed POGS was only compared with CPLEX optimization technique, since the previous study 15 had compared the CPLEX optimization method with other clinically available approaches such as DSO and IPSA. The CPLEX algorithm was found as efficient in optimization time and effective in plan quality for RSBT techniques when compared to other clinically available approaches of DSO and IPSA.
The POGS algorithm can be thought of as the engine that enables shield angle selection algorithms, which require multiple optimizations having different azimuthal angles to be run quickly, to operate quickly enough for clinical implementation. For example, with all 72 possible beam angles of multiples of 5 degrees for possible shield angle selection, POGS takes about 3.2 min (2.7 s 9 72 = 194.4 s), while CPLEX takes about 57.5 min (47.9 s 9 72 = 3448.8 s), where 2.7 s and 47.9 s are the average execution time to solve the optimization problem in Table IV . In this case, the operation time to solve the RSBT optimization problem becomes a burden to use in clinic, and the clinical benefit of using the POGS algorithm can be much clearly shown. A partial shield with 45°azimuthal angle in H-RSBT was used for the numerical experiments. However, finding the optimal shield angle in H-RSBT is still under investigation. It may be possible to find the optimal shield angle (opening) and the radiation exposure time for each beamlet by including different dose matrices obtained with different angle sizes in the optimization problem.
For the purpose of comparison study, VOIs were applied to reduce the size of the ADOS optimization problem. Instead of applying VOIs, all voxels can be included in the optimization problem under the expectation of better treatment quality with heavy computation. Since parallel computing and GPUbased high performance computing can play an important role in solving extremely large-scale optimization problems, there is a rising question about the usability of POGS in parallel computing environment or GPU-based implantation. The implementation of POGS in such environment is beyond the scope of this study.
POGS (and ADMM) has been used in previous research on intensity-modulated radiation therapy (IMRT), 17,32 fluence map optimization, 33 and external beam radiotherapy (EBRT) optimization. 34 To the best of our knowledge, our paper is the first work to use POGS in brachytherapy, including the mechanically feasible delivery system called H-RSBT.
While H-RSBT uses a shield around catheter of radiation source which is inserted into a brachytherapy applicator with helical keyways, DMBT approach is performed using a direction-modulated brachytherapy tandem with peripheral holes, called core, in which high-dose radiation source is placed and translated longitudinally, and the core in DMBT provides a substantial amount of shielding around the source. 31 However, due to the presence of a fairly thick tungsten core in DMBT applicator, this technique is not an MRI compatible technique while both conventional HDR-BT, which is performed in the absence of any shielding material around the source, and H-RSBT techniques are MR-compatible. Due to the similar mechanisms among HDR-BT, H-RSBT, and DMBT, the proposed POGS method is also applicable to HDR-BT as well as DMBT with modifications on dose matrix and TV norm.
CONCLUSIONS
POGS substantially reduced treatment plan optimization time around 18 times for RSBT with similar HR-CTV D 90 , OAR D 2cc values, and EQD2 dose distributions compared to those obtained using CPLEX, which is significant progress toward clinical implementation of RSBT. For all cervical cancer patients, total optimization times were 32.1-65.4 s for CPLEX and 2.1-3.9 s for POGS.
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